Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer-related Molecular Pathways, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and Circular RNAs in diseases.
MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
Additional file 2 of Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions
Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?
Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome
<i>MCM7</i>and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
MYC Is Activated by USP2a-Mediated Modulation of MicroRNAs in Prostate Cancer
P3.10 Microrna Profiling in Gastric Cancer